Amino.Desk

Tesofensine

Updated Nov 17, 2026 · Clinical review: pending

Tesofensine is a pill that suppresses appetite by acting on three brain chemicals. It is not a peptide. A mid-stage trial showed strong weight loss, and the same trial showed the problem that has kept it from approval: it raises heart rate and blood pressure.

What it is

Tesofensine blocks the reuptake of serotonin, noradrenaline and dopamine. It was first developed for Parkinson's and Alzheimer's disease, where it did not work. Weight loss in those trials led to its being tested for obesity.

What the evidence shows

The main evidence is one Phase 2 trial published in The Lancet in 2008. It followed 203 adults with obesity at five Danish centers for 24 weeks, testing 0.25 mg, 0.5 mg and 1 mg a day against placebo. At 0.5 mg, average weight loss was 9.2%, against 2.0% on placebo. That was about double what the weight-loss drugs of the time achieved.

The 1 mg dose produced more weight loss and more side effects. A later program in Mexico, reported as 372 patients, broadly matched the weight loss. No large trial has tested heart outcomes.

Legal status

Reported dosing

No approved dose exists in the US.

The Phase 2 trial tested 0.25 mg, 0.5 mg and 1 mg once a day, and later work continued with 0.5 mg. Those are trial doses in monitored studies, not a recommendation. The drug stays in the body a long time, with a half-life reported at about nine days, so its effects persist for weeks after stopping.

Safety

Common questions

Is tesofensine a peptide?

No. It is a small-molecule drug taken as a capsule.

How much weight did people lose on tesofensine?

In the main trial, 9.2% of body weight over 24 weeks at 0.5 mg a day, against 2.0% on placebo.

Is tesofensine FDA-approved?

No. There is no approved product in the US.

Why was it not approved?

It raises heart rate and blood pressure, and no large trial has tested its effect on heart outcomes.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy